– Reuters
HC Wainwright & Co. Reiterates Buy on HOOKIPA Pharma, Maintains $8 Price Target
HC Wainwright & Co. analyst Arthur He reiterates HOOKIPA Pharma (NASDAQ:HOOK) with a Buy and maintains $8 price target.
Related Posts
Big Lots’ Tough Near-Term Trends & Elevated Pressure On Profitability Keeps This Analyst On The Sidelines
Telsey Advisory Group analyst Joseph Feldman reiterated a Market Perform rating on the shares of Big Lots Inc (NYSE:BIG) with a price…
‘Missouri Marijuana Legalization Initiative Will Appear On November Ballot, State Announces’ -Marijuana Moment Report
https://www.marijuanamoment.net/missouri-marijuana-legalization-initiative-will-appear-on-november-ballot-state-announces/
BMO Capital Maintains Market Perform on Atlantica Sustainable, Raises Price Target to $36
BMO Capital analyst James Thalacker maintains Atlantica Sustainable (NASDAQ:AY) with a Market Perform and raises the price target from $33 to $36.